» Authors » Marzena Welnicka-Jaskiewicz

Marzena Welnicka-Jaskiewicz

Explore the profile of Marzena Welnicka-Jaskiewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 365
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Senkus E, Szade J, Pieczynska B, Zaczek A, Brozek I, Radecka B, et al.
Breast . 2013 May; 22(4):425-30. PMID: 23642527
Rationale: Bilateral breast cancers (BBC) and breast cancers coexisting with ovarian cancer (BOCS) are associated with genetic predisposition more frequently than sporadic cases. We compared the phenotypes of these tumors...
12.
Markiewicz A, Ahrends T, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Jaskiewicz J, et al.
J Transl Med . 2012 Nov; 10:226. PMID: 23157797
Background: Breast cancers are phenotypically and genotypically heterogeneous tumors containing multiple cancer cell populations with various metastatic potential. Aggressive tumor cell subpopulations might more easily be captured in lymph nodes...
13.
Zaczek A, Markiewicz A, Seroczynska B, Skokowski J, Jaskiewicz J, Pienkowski T, et al.
Oncologist . 2012 Aug; 17(10):1246-55. PMID: 22871798
Background: Previous studies showed the prognostic and predictive impact of human epidermal growth factor receptor 2 (HER-2) gene alterations analyzed separately and jointly with topoisomerase II α (TOP2A) gene alterations;...
14.
Supernat A, Markiewicz A, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Sejda A, et al.
Appl Immunohistochem Mol Morphol . 2012 May; 20(2):103-7. PMID: 22553809
Ecto-5'-nucleotidase (CD73) is a membrane-bound enzyme, which catalyzes the conversion of adenosine monophosphate to adenosine. CD73 has been postulated to play an important role in carcinogenesis, as adenosine promotes tumor...
15.
Zaczek A, Markiewicz A, Supernat A, Bednarz-Knoll N, Brandt B, Seroczynska B, et al.
Pathol Oncol Res . 2012 Mar; 18(4):885-94. PMID: 22426810
The aim of this study was to analyze the occurrence of TOP2A gene amplification and chromosome 17 polysomy in patients with early breast cancer and to correlate the status of...
16.
Sinacki M, Badzio A, Welnicka-Jaskiewicz M, Bogaerts J, Piccart M, Therasse P, et al.
Breast . 2010 Sep; 20(2):145-50. PMID: 20870406
Background And Methods: The optimal treatment of locally advanced breast cancer (LABC) remains undetermined. We analyzed factors influencing local therapy in LABC in a pooled material including three large clinical...
17.
Zaczek A, Markiewicz A, Jaskiewicz J, Pienkowski T, Rhone P, Jassem J, et al.
Clin Biochem . 2010 May; 43(10-11):891-8. PMID: 20441774
Objectives: The objective of this study was to develop a new real time PCR-based method for quantitative detection of topoisomerase II alpha (TOP2A) aberrations and to evaluate its clinical utility...
18.
Zaczek A, Welnicka-Jaskiewicz M, Bielawski K, Jaskiewicz J, Badzio A, Olszewski W, et al.
J Cancer Res Clin Oncol . 2007 Jul; 134(2):271-9. PMID: 17661082
Aim: The aim of the study was to analyze the occurrence of abnormal gene copy numbers of all HER oncogenes and to correlate these alterations to other clinicopathological variables in...
19.
Morales L, Canney P, Dyczka J, Rutgers E, Coleman R, Cufer T, et al.
Eur J Cancer . 2006 Dec; 43(2):331-40. PMID: 17134892
Background: The contribution of adjuvant tamoxifen in breast cancer patients after receiving adjuvant chemotherapy is not fully established. We investigated the impact of tamoxifen, given sequentially after completion of adjuvant...
20.
Welnicka-Jaskiewicz M, Zaczek A, Brandt B, Bielawski K, Jaskiewicz J, Konopa K, et al.
Eur J Cancer . 2006 Jun; 42(12):1698-701. PMID: 16765588
The aim of this study was to determine polymorphism of repeated sequences (CA)(n) in the ERBB-1 gene. The study group included 197 breast cancer patients and 180 healthy women. DNA...